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Purpose
Several single center studies have shown that Delayed-
enhancement (MRI DE-MRI) can predict functional recov-
ery after revascularization [1,2]. The purpose of this study
was to determine the prognostic value of DE-MRI for pre-
dicting recovery of regional wall motion abnormality after
revascularization in patients with chronic coronary artery
disease (CAD) in a prospective, international, multi-
center trial.
Methods
183 patients (167 men, age: 59.1 ± 9.7 years) with angio-
graphically confirmed CAD and resting wall motion
abnormality (WMA) scheduled for coronary bypass (n =
101) or angioplasty (n = 82) were enrolled from 9 institu-
tions (US, Europe, and Asia) using a standardized imaging
protocol. Functional and DE-MRI were performed within
30 days prior to and 5.6 ± 2.4 months after intervention.
Data Acquisition
All images were acquired on a Philips 1.5 T imager with
VCG gating, and a five-element synergy cardiac coil was
used for signal reception. A steady-state free precession
(SSFP) sequence was used for cardiac cine imaging: TR/
TE/flip: 2.7 msec/1.3 msec/65°; FOV: 320 mm, matrix:
160 × 160, slice thickness: 10 mm; slice gap: 0 mm;
acquired voxel size: 2.0 × 2.0 × 10.0 mm and recon-
structed voxel size: 1.3 × 1.3 × 10.0 mm; temporal resolu-
tion: 25–40 msec depending on heart rate. Cine SSFP
images were acquired in the two long – axis orientations
(vertical long axis and 4 chambers) and short axis orienta-
tions (10 to 12 contiguous short-axis cine SSFP images
from mitral valve plane through the apex). DE-MRI
images were acquired 15 minutes after administering 0.2
mmol/kg of gadolinium-chelate (OptiMARK™) in the
same orientation as the cine images. The DE-MRI
sequence was an inversion-recovery prepared, segmented
gradient echo acquisition with the following acquisition
parameters: field-of-view: 384 × 384 mm; matrix size: 256
× 256; acquired voxel size: 1.5 × 1.5 × 10 mm; 32 phase
encoding steps per RR interval; TR/TE/flip: 4.6/1.9/15°;
NSA: 2; acquisition time per slice: 16 RR intervals. The
inversion delay time (TI) between the inversion pulse and
the beginning of the data acquisition necessary to null the
signal from normal myocardium was determined by the
Look-Locker sequence. The data acquisition was timed to
occur in diastole to minimize cardiac motion.
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Cine and delayed – enhanced images were analyzed based
on the model proposed by Kim R et al [1] in which the left
ventricle was divided into 12 equiangular segments on 8
– 10 short – axis views, depending on the length of ventri-
cle. Progressively worsening segmental WMA and increas-
ing extent of DE were scored on a scale of 0 – 4 [1].
Results
At baseline, 5580/12274 (46%) segments had abnormal
contractility, and 2974/12274 (24%) segments had DE.
Improvement in contractility of impaired segments fol-
lowing revascularization correlated inversely with the
transmural extent of scar (r2 = 0.9, Fig. 1). For instance,
72% of dysfunctional segments without evidence of scar
at baseline showed improvement in contractility follow-
ing revascularization, and remarkably, 52% of such seg-
ments had complete recovery of function (p < 0.001).
Conversely, less than a fourth (250/1438, 17%) of the
segments with near or complete transmural scar (score 3
and 4) had any functional recovery (P value < 0.001).
Conclusion
The results from the first, global, multi-center trial deter-
mined that DE-MRI is a robust predictor of functional
recovery after revascularization.
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The Multicenter Viability Trial confirmed the prognostic 
value of DE-MRI for predicting recovery of left ventricular 
function recovery after revascularization in patients with 
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